As of 2025, Hengrui led all Chinese biotech companies in licensing deals with global pharmaceutical companies, with its agreement with GSK valued at ** billion U.S. dollars. CSPC ranked second, with a licensing deal with AstraZeneca worth more than **** billion U.S. dollars.Â
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Alvarez & Marsal . (January 9, 2026). Leading Chinese biotech to global pharma licensing deals in 2025 (in billion U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 31, 2026, from /statistics/1662762/chinese-biotech-to-global-pharma-licensing-deals/
Alvarez & Marsal . "Leading Chinese biotech to global pharma licensing deals in 2025 (in billion U.S. dollars)." Chart. January 9, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 31, 2026. /statistics/1662762/chinese-biotech-to-global-pharma-licensing-deals/
Alvarez & Marsal . (2026). Leading Chinese biotech to global pharma licensing deals in 2025 (in billion U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 31, 2026. /statistics/1662762/chinese-biotech-to-global-pharma-licensing-deals/
Alvarez & Marsal . "Leading Chinese Biotech to Global Pharma Licensing Deals in 2025 (in Billion U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 9 Jan 2026, /statistics/1662762/chinese-biotech-to-global-pharma-licensing-deals/
Alvarez & Marsal , Leading Chinese biotech to global pharma licensing deals in 2025 (in billion U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1662762/chinese-biotech-to-global-pharma-licensing-deals/ (last visited July 31, 2026)
Leading Chinese biotech to global pharma licensing deals in 2025 (in billion U.S. dollars) [Graph], Alvarez & Marsal , January 9, 2026. [Online]. Available: /statistics/1662762/chinese-biotech-to-global-pharma-licensing-deals/
